Vanilloid receptor 1 (TRPV1) expression in lingual nerve neuromas from patients with or without symptoms of burning pain

Brain Research

Volumn 1127, Issue 1, 2007, Pages 59-65

  Biggs, James E ^a   Yates, Julian M ^a   Loescher, Alison R ^a   Clayton, Nick M ^b   Boissonade, Fiona M ^a   Robinson, Peter P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Burning pain; Dysaesthesia; Lingual nerve; Nerve injury; TRPV1

Indexed keywords

GENE PRODUCT; VANILLOID RECEPTOR 1;

ADULT; ARTICLE; BURNING SENSATION; CANCER PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DYSESTHESIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LINGUAL NERVE; MALE; MICROSURGERY; NERVE INJURY; NEUROMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SYMPTOM; VISUAL ANALOG SCALE;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; LINGUAL NERVE; MALE; MIDDLE AGED; MOLAR, THIRD; NEURALGIA; NEUROMA; NOCICEPTORS; ORAL SURGICAL PROCEDURES; PAIN, INTRACTABLE; PARESTHESIA; POSTOPERATIVE COMPLICATIONS; TRIGEMINAL NERVE DISEASES; TRPV CATION CHANNELS;

EID: 33845186328     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.10.014     Document Type: Article

References (27)

1. Berkley K.J. Sex differences in pain. Behav. Brain Sci. 20 (1997) 371-380 (discussion 435-513)
2. Biggs, J.E., Yates, J.M., Loescher, A.R., Clayton, N.M., Boissonade, F.M., Robinson, P.P., 2006. Changes in vanilloid receptor 1 (TRPV1) following lingual nerve injury, Eur. Pain, (in press; doi: 10.1016/j.ejpain.2006.02.004).
3. Caterina M.J., and Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24 (2001) 487-517
4. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
5. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
6. Chancellor M.B., and de Groat W.C. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J. Urol. 162 (1999) 3-11
7. Denda M., Fuziwara S., Inoue K., Denda S., Akamatsu H., Tomitaka A., and Matsunaga K. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem. Biophys. Res. Commun. 285 (2001) 1250-1252
8. Fukuoka T., Tokunaga A., Tachibana T., Dai Y., Yamanaka H., and Noguchi K. VR1, but not P2X(3), increases in the spared L4 DRG in rats with L5 spinal nerve ligation. Pain 99 (2002) 111-120
9. Gibson S.J., and Farrell M. A review of age differences in the neurophysiology of nociception and the perceptual experience of pain. Clin. J. Pain 20 (2004) 227-239
10. Guo A., Vulchanova L., Wang J., Li X., and Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci. 11 (1999) 946-958
11. Honore P., Wismer C.T., Mikusa J., Zhu C.Z., Zhong C., Gauvin D.M., Gomtsyan A., El Kouhen R., Lee C.H., Marsh K., Sullivan J.P., Faltynek C.R., and Jarvis M. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J. Pharmacol. Exp. Ther. 314 (2005) 410-421
12. Hudson L.J., Bevan S., Wotherspoon G., Gentry C., Fox A., and Winter J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci. 13 (2001) 2105-2114
13. Ikeda H., Tokita Y., and Suda H. Capsaicin-sensitive A delta fibers in cat tooth pulp. J. Dent. Res. 76 (1997) 1341-1349
14. Jensen T.S. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur. J. Pain 6 (2002) A61-A68 (Suppl.)
15. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., and Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3655-3660
16. Miyamoto R., Tokuda M., Sakuta T., Nagaoka S., and Torii M. Expression and characterization of vanilloid receptor subtype 1 in human dental pulp cell cultures. J. Endod. 31 (2005) 652-658
17. Morgan C.R., Rodd H.D., Clayton N., Davis J.B., and Boissonade F.M. Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain. J. Orofac. Pain 19 (2005) 248-260
18. Padilla M., Clark G.T., and Merrill R.L. Topical medications for orofacial neuropathic pain: a review. J. Am. Dent. Assoc. 131 (2000) 184-195
19. Pomonis J.D., Harrison J.E., Mark L., Bristol D.R., Valenzano K.J., and Walker K. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 306 (2003) 387-393
20. Robinson P.P. Nerve injuries resulting from the removal of impacted teeth. In: Andreasen J., Petersen J., and Laskin D. (Eds). Textbook and Colour Atlas of Tooth Impactions Diagnosis, Treatment and Prevention (1997), Munksgaard International Publishers, Monksgaard 469-490
21. Robinson P.P., Loescher A.R., Yates J.M., and Smith K.G. Current management of damage to the inferior alveolar and lingual nerves as a result of removal of third molars. Br. J. Oral Maxillofac. Surg. 42 (2004) 285-292
22. Stenholm E., Bongenhielm U., Ahlquist M., and Fried K. VRl- and VRL-l-like immunoreactivity in normal and injured trigeminal dental primary sensory neurons of the rat. Acta Odontol. Scand. 60 (2002) 72-79
23. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., and Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21 (1998) 531-543
24. Tympanidis P., Casula M.A., Yiangou Y., Terenghi G., Dowd P., and Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur. J. Pain 8 (2004) 129-133
25. Vora A.R., Loescher A.R., Craig G.T., Boissonade F.M., and Robinson P.P. A light microscopical study on the structure of traumatic neuromas of the human lingual nerve. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 99 (2005) 395-403
26. Vora A.R., Loescher A.R., Boissonade F.M., and Robinson P.P. Ultrastructural characteristics of axons in traumatic neuromas of the human lingual nerve. J. Orofac. Pain 19 (2005) 22-33
27. Walker K.M., Urban L., Medhurst S.J., Patel S., Panesar M., Fox A.J., and McIntyre P. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 304 (2003) 56-62